AI Portfolio Summary
In 2025 Q4, NEXTBio Capital Management LP maintained a portfolio of 23 distinct positions. The most significant new addition to the portfolio was TERNS PHARMACEUTICAL, which now represents 13.06% of the total fund value.
Total Positions
23
Quarter
2025 Q4
Top Holding
TERN (13.1%)
Top 10 Concentration
70.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-23 of 23
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TERN
TERNS PHARMACEU...
|
Unknown | 13.06% | — |
#1
Prev: #—
|
7.2 | 551,190 | no change |
NEW
|
551,190 | $22,268,076 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Unknown | 11.76% | — |
#2
Prev: #—
|
6.7 | 229,619 | no change |
NEW
|
229,619 | $20,054,923 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VOR
VOR BIOPHARMA I...
|
Unknown | 7.67% | — |
#3
Prev: #—
|
5.1 | 999,967 | no change |
NEW
|
999,967 | $13,079,568 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Unknown | 6.86% | — |
#4
Prev: #—
|
4.7 | 321,983 | no change |
NEW
|
321,983 | $11,691,203 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STTK
SHATTUCK LABS I...
|
Unknown | 6.74% | — |
#5
Prev: #—
|
4.7 | 3,149,907 | no change |
NEW
|
3,149,907 | $11,497,161 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VSTM
VERASTEM INC
|
Unknown | 5.92% | — |
#6
Prev: #—
|
4.4 | 1,307,330 | no change |
NEW
|
1,307,330 | $10,092,588 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PVLA
PALVELLA THERAP...
|
Unknown | 5.08% | — |
#7
Prev: #—
|
4.0 | 82,686 | no change |
NEW
|
82,686 | $8,654,744 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XENE
XENON PHARMACEU...
|
Unknown | 4.83% | — |
#8
Prev: #—
|
3.9 | 183,704 | no change |
NEW
|
183,704 | $8,233,613 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RYTM
RHYTHM PHARMACE...
|
Unknown | 4.24% | — |
#9
Prev: #—
|
3.7 | 67,586 | no change |
NEW
|
67,586 | $7,234,405 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Unknown | 3.85% | — |
#10
Prev: #—
|
3.5 | 94,443 | no change |
NEW
|
94,443 | $6,568,511 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IVA
INVENTIVA SA
|
Unknown | 3.54% | — |
#11
Prev: #—
|
3.4 | 1,298,701 | no change |
NEW
|
1,298,701 | $6,038,960 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPX
COMPASS THERAPE...
|
Unknown | 3.51% | — |
#12
Prev: #—
|
3.4 | 1,114,005 | no change |
NEW
|
1,114,005 | $5,982,207 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPS
COMPASS PATHWAY...
|
Unknown | 3.05% | — |
#13
Prev: #—
|
3.2 | 752,631 | no change |
NEW
|
752,631 | $5,193,154 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ORIC
ORIC PHARMACEUT...
|
Unknown | 2.95% | — |
#14
Prev: #—
|
3.2 | 615,720 | no change |
NEW
|
615,720 | $5,036,590 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CRESCENT BIOPHA...
|
—
|
Unknown | 2.59% | — |
#15
Prev: #—
|
3.0 | 372,856 | no change |
NEW
|
372,856 | $4,422,072 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
PCVX
VAXCYTE INC
|
Unknown | 2.58% | — |
#16
Prev: #—
|
3.0 | 95,485 | no change |
NEW
|
95,485 | $4,405,678 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EVMN
EVOMMUNE INC
|
Unknown | 2.29% | — |
#17
Prev: #—
|
2.9 | 228,286 | no change |
NEW
|
228,286 | $3,908,256 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Unknown | 2.00% | — |
#18
Prev: #—
|
2.8 | 95,819 | no change |
NEW
|
95,819 | $3,403,491 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Unknown | 1.99% | — |
#19
Prev: #—
|
2.8 | 42,778 | no change |
NEW
|
42,778 | $3,397,001 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OCS
OCULIS HOLDING ...
|
Unknown | 1.75% | — |
#20
Prev: #—
|
2.7 | 149,750 | no change |
NEW
|
149,750 | $2,990,508 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZLAB
ZAI LAB LTD
|
Unknown | 1.69% | — |
#21
Prev: #—
|
2.7 | 163,362 | no change |
NEW
|
163,362 | $2,881,706 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KALV
KALVISTA PHARMA...
|
Unknown | 1.25% | — |
#22
Prev: #—
|
2.5 | 131,796 | no change |
NEW
|
131,796 | $2,128,505 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACET
ADICET BIO INC
|
Unknown | 0.78% | — |
#23
Prev: #—
|
2.3 | 157,827 | no change |
NEW
|
157,827 | $1,328,903 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-23 of 23 holdings